Covid-19 Primary Care Resources

Individuals aged 12 years and over with severe immunosuppression should receive a 3rd primary dose of Covid vaccination

Children age 12 and over who live with immunosuppressed people and young people age 16 and over are now eligible for vaccination

Signs, symptoms, when to refer and when to investigate in primary care

No clear agreement on vaccine effectiveness in immunosuppressed groups

An update on Variants of Concern and UK vaccine effectiveness data

Updated guidance and safety data from the RCOG and PHE Greenbook

A list of resources including tools to aid discussions on risk:benefit including blood clotting risk

Maximising the safety of adults with chronic kidney disease during the pandemic

Guidance on vaccination individual on immunosuppressive treatment

Guidance for vaccinating individuals on treatment with DMARDs

GPs are encouraged to apply a flexible approach to defining SMI

Guidance on vaccination individuals undergoing steroid treatments

Guide on vaccinating individuals undergoing chemotherapy

Guidance on the Pfizer/BioNTech, AstraZeneca and Moderna Covid-19 vaccinations for people with pre-existing allergies

Vaccinating patients on specific drug treatments

An updated summary of current guidance: most infections are spread through close contact

Updated vaccination guidance for individuals with clotting and bleeding disorders and those on anticoagulant therapy

The most frequently reported adverse effects to the different vaccines and when to report an adverse effect

Advice on prioritisation for the Covid-19 vaccine programme rollout and guidance on prescribing the vaccines